C. Peedell's Profile

Role	Title	Level	Year	L/R
🐜	Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial 48 auth. Nicholas D. James, Nicholas D. James, M. Sydes, N. Clarke, M. Mason, D. Dearnaley, M. Spears, A. Ritchie, C. Parker, J. Russell, G. Attard, J. Bono, W. Cross, Robert Jones, G. Thalmann, ... C. Amos, D. Matheson, R. Millman, M. Alzouebi, S. Beesley, A. Birtle, S. Brock, R. Cathomas, P. Chakraborti, S. Chowdhury, A. Cook, T. Elliott, J. Gale, S. Gibbs, J. Graham, J. Hetherington, R. Hughes, R. Laing, F. McKinna, D. McLaren, J. O’Sullivan, O. Parikh, C. Peedell, A. Protheroe, A. Robinson, N. Srihari, R. Srinivasan, J. Staffurth, S. Sundar, S. Tolan, D. Tsang, J. Wagstaff, M. Parmar	10	2016	10 🐜
🐜	Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol 55 auth. M. Sydes, M. Spears, M. Mason, N. Clarke, D. Dearnaley, J. D. Bono, G. Attard, S. Chowdhury, W. Cross, S. Gillessen, S. Gillessen, Z. Malik, Robert J. Jones, Robert Jones, C. Parker, ... A. Ritchie, J. Russell, J. Russell, R. Millman, D. Matheson, C. Amos, C. Gilson, A. Birtle, S. Brock, L. Capaldi, P. Chakraborti, A. Choudhury, A. Choudhury, L. Evans, D. Ford, J. Gale, S. Gibbs, D. Gilbert, R. Hughes, D. McLaren, J. Lester, A. Nikapota, J. O’Sullivan, J. O’Sullivan, O. Parikh, C. Peedell, A. Protheroe, S. Rudman, R. Shaffer, D. Sheehan, M. Simms, N. Srihari, R. Strebel, S. Sundar, S. Tolan, D. Tsang, M. Varughese, J. Wagstaff, M. Parmar, N. James	7	2018	7 🐜
🐜	Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol 154 auth. G. Attard, L. Murphy, N. Clarke, W. Cross, Robert J. Jones, C. Parker, S. Gillessen, A. Cook, C. Brawley, C. Amos, N. Atako, C. Pugh, Michelle M. C. Buckner, S. Chowdhury, Z. Malik, ... J. Russell, C. Gilson, H. Rush, J. Bowen, A. Lydon, I. Pedley, J. O’Sullivan, A. Birtle, J. Gale, N. Srihari, Carys W Thomas, J. Tanguay, J. Wagstaff, P. Das, Emma Gray, Mymoona Alzoueb, O. Parikh, A. Robinson, I. Syndikus, J. Wylie, A. Zarkar, G. Thalmann, J. Bono, D. Dearnaley, M. Mason, D. Gilbert, R. Langley, R. Millman, D. Matheson, M. Sydes, L. Brown, M. Parmar, Nicholas D. James, E. Jones, K. Hyde, H. Glen, S. Needleman, U. McGovern, D. Sheehan, S. Paisey, R. Shaffer, M. Beresford, E. Porfiri, D. Fackrell, Ling-hui Lee, T. Sreenivasan, S. Brock, Simon Brown, A. Bahl, Mike Smith-Howell, C. Woodward, M. Phan, D. Mazhar, K. Narahari, F. Douglas, Ajay Kumar, A. Hamid, A. Ibrahim, D. Muthukumar, M. Simms, J. Worlding, A. Tran, M. Kagzi, C. Pezaro, Virgil Sivoglo, B. Masters, Pek Keng-Koh, C. Manetta, D. McLaren, Nishi Gupta, S. Boussios, H. Taylor, J. Graham, C. Perna, L. Melcher, Warren C. Grant, A. Sabharwal, U. Hofmann, R. Dealey, N. McPhail, R. Brierly, L. Capaldi, N. Sidek, P. Whelan, P. Robson, A. Falconer, S. Rudman, S. Vivekanandan, Vinod Mullessey, M. Vilarino-Varela, V. Khoo, K. Tipples, M. Afshar, P. Brulinski, V. Sangar, C. Peedell, A. Azzabi, P. Hoskin, Viwod Mullassery, S. Sundar, Yakhub Khan, R. Conroy, A. Protheroe, J. Carser, P. Rogers, K. Tarver, S. Gibbs, M. M. Khan, M. Hingorani, S. Crabb, M. Alameddine, N. Bhalla, R. Hughes, J. Logue, D. Leaning, Salil Vengalil, D. Ford, G. Walker, A. Shaheen, Omar Khan, Andrew Chan, I. Ahmed, S. Hilman, I. Sayers, A. Nikapota, D. Bloomfield, T. Porter, J. Joseph, C. Rentsch, R. P. Mestre, E. Roggero, Jörg Beyer, M. Borner, R. Strebel, D. Berthold, D. Engeler, Hubert John, Razvan Popescu, Donat Durr	7	2021	7 🐜
🐜	SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status. 8 auth. J. Maguire, I. Khan, R. McMenemin, N. O'Rourke, S. McNee, V. Kelly, ... C. Peedell, M. Snee	6	2014	6 🐜
🐜	Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic 14 auth. C. Faivre-Finn, J. Fenwick, K. Franks, S. Harrow, Matthew Q. Hatton, C. Hiley, J. Mcaleese, Fiona McDonald, J. O’Hare, C. Peedell, ... C. Powell, T. Pope, R. Rulach, E. Toy	5	2020	5 🐜
🐜	Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience 22 auth. Justin Lee, M. Bates, E. Shepherd, S. Riley, Michael Henshaw, P. Metherall, Jim Daniel, A. Blower, D. Scoones, Michele Wilkinson, ... N. Richmond, C. Robinson, P. Cuculich, G. Hugo, N. Seller, R. McStay, N. Child, A. Thornley, N. Kelland, P. Atherton, C. Peedell, M. Hatton	5	2021	5 🐜
🦁	Further privatisation is inevitable under the proposed NHS reforms C. Peedell	5	2011	5 🦁
🐜	An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer 18 auth. R. Rulach, D. Ball, K. Chua, M. Dahele, D. de Ruysscher, K. Franks, D. Gomez, M. Guckenberger, G. Hanna, A. Louie, ... D. Moghanaki, D. Palma, C. Peedell, A. Salem, S. Siva, G. Videtic, A. Chalmers, S. Harrow	4	2021	4 🐜
🐜	SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection 24 auth. K. Franks, L. McParland, J. Webster, D. Baldwin, D. Sebag‐Montefiore, M. Evison, R. Booton, C. Faivre-Finn, B. Naidu, J. Ferguson, ... C. Peedell, M. Callister, M. Kennedy, J. Hewison, J. Bestall, W. Gregory, P. Hall, F. Collinson, C. Olivier, R. Naylor, S. Bell, P. Allen, A. Sloss, M. Snee	4	2020	4 🐜
🐜	Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness 47 auth. Prabir R Cook, A. Cross, William R Dearnaley, David P Gale, B. Woods, E. Sideris, M. Sydes, M. Gannon, M. Parmar, M. Alzouebi, G. Attard, A. Birtle, S. Brock, R. Cathomas, P. Chakraborti, ... A. Cook, W. Cross, D. Dearnaley, J. Gale, S. Gibbs, J. Graham, R. Hughes, Robert J. Jones, R. Laing, M. Mason, D. Matheson, D. McLaren, R. Millman, J. O’Sullivan, O. Parikh, C. Parker, C. Peedell, A. Protheroe, A. Ritchie, M. Russell, M. Simms, N. Srihari, R. Srinivasan, J. Staffurth, S. Sundar, G. Thalmann, S. Tolan, A. Tran, D. Tsang, J. Wagstaff, N. James, M. Sculpher	4	2018	4 🐜
🦁	Is there a standard of care for the radical management of non-small cell lung cancer involving the apical chest wall (Pancoast tumours)? C. Peedell, J. Dunning, A. Bapusamy	4	2010	4 🦁